LONG-TERM EFFECTS OF ETANERCEPT AND CERTOLIZUMAB PEGOL TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：2
|
作者：
Vegh, Edit [1 ]
Vancsa, Andrea [1 ,2 ]
Kerekes, Gyoergy
Balazs, Fruzsina [1 ]
Pogacsas, Lilla [1 ]
Bodnar, Nora [1 ]
Szuecs, Gabriella [1 ]
Szanto, Sandor [1 ]
Szekanecz, Zoltan [1 ]
机构：
[1] Univ Debrecen, Med & Hlth Sci Ctr, Inst Med, Dept Rheumatol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Dept Angiol, H-4012 Debrecen, Hungary
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2013-205124.82
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1.83
引用
收藏
页码：A36 / A37
页数：6
相关论文
共 50 条
  • [41] ETANERCEPT SERUM TROUGH LEVELS ARE CORRELATED WITH CLINICAL ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS WITH LONG-TERM TREATMENT WITH ETANERCEPT
    Plasencia, C.
    Pascual-Salcedo, D.
    Alcozer, P.
    Garcia-Carazo, S.
    Franco, K. N.
    Cajigas, D.
    Bonilla, G.
    Lojo, L.
    Nuno, L.
    Villalba, A.
    Peiteado, D.
    Arribas, F.
    Lopez-Casla, M. T.
    Martin-Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 428 - 428
  • [42] Clinical Relevance of Etanercept Levels and Anti-Etanercept Antibodies in Long-Term Treatment of Rheumatoid Arthritis Patients
    Drynda, Susanne
    Kekow, Joern
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [43] Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice
    Arends, S.
    Brouwer, E.
    Efde, M.
    van der Veer, E.
    Bootsma, H.
    Wink, F.
    Spoorenberg, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : 61 - 68
  • [44] Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis
    Edit Végh
    György Kerekes
    Anita Pusztai
    Attila Hamar
    Szilvia Szamosi
    Andrea Váncsa
    Levente Bodoki
    Lilla Pogácsás
    Fruzsina Balázs
    Katalin Hodosi
    Andrea Domján
    Sándor Szántó
    Zoltán Nagy
    Zoltán Szekanecz
    Gabriella Szűcs
    Rheumatology International, 2020, 40 : 427 - 436
  • [45] Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis
    Vegh, Edit
    Kerekes, Gyorgy
    Pusztai, Anita
    Hamar, Attila
    Szamosi, Szilvia
    Vancsa, Andrea
    Bodoki, Levente
    Pogacsas, Lilla
    Balazs, Fruzsina
    Hodosi, Katalin
    Domjan, Andrea
    Szanto, Sandor
    Nagy, Zoltan
    Szekanecz, Zoltan
    Szucs, Gabriella
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (03) : 427 - 436
  • [46] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [47] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [48] Long-term effects of early treatment in patients with rheumatoid arthritis
    van der Heijde, Desiree
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (05): : 258 - 259
  • [49] Long-term effects of early treatment in patients with rheumatoid arthritis
    Désirée van der Heijde
    Nature Clinical Practice Rheumatology, 2007, 3 : 258 - 259
  • [50] Comparison of Long-Term Clinical Outcome With Etanercept Treatment and Adalimumab Treatment of Rheumatoid Arthritis With Respect to Immunogenicity
    Krieckaert, Charlotte L.
    Jamnitski, Anna
    Nurmohamed, Michael T.
    Kostense, Piet J.
    Boers, Maarten
    Wolbink, Gertjan
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 3850 - 3855
12345